Dosimetric quality and acute toxicity in HDR-brachytherapy as monotherapy in low risk prostate cancer

被引：0
|
作者：
Isaak, B [1 ]
Thalmann, G [1 ]
Vock, J [1 ]
Rentsch, CA [1 ]
Manser, P [1 ]
Mini, R [1 ]
Greiner, RH [1 ]
Kolotas, C [1 ]
Aebersold, D [1 ]
机构：
[1] Univ Bern, Dept Radiat Oncol, Inselspital, Bern, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Acute toxicity of HDR-brachytherapy as monotherapy for low-risk prostate cancer: Analysis of 297 patients treated with two different fractionation schemes
    Skazikis, G.
    Kurek, R.
    Baltas, D.
    Tselis, N.
    Dankwart, R.-O.
    Tunn, U.-W.
    Zamboglou, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 125 - 125
  • [2] HDR BRACHYTHERAPY AS MONOTHERAPY FOR EARLY STAGE PROSTATE CANCER: ACUTE TOXICITY
    Aluwini, S.
    van Rooij, P.
    Kirkels, W.
    Bangma, C.
    Kolkman-Deurloo, I. K.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S283 - S284
  • [3] HDR brachytherapy as monotherapy for low and intermediate risk prostate cancer
    Gaudet, M.
    Pharand-Charbonneau, M.
    Wright, D.
    Desrosiers, M.
    Haddad, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1188 - S1188
  • [4] HDR brachytherapy in monotherapy of one fraction in patients with prostate cancer at low risk
    Orduz Arenas, A. C.
    Jimenez Garcia, I.
    Martinez Gutierrez, R.
    Cucarella Beltran, P.
    Blanco Parajon, S.
    Gonzalez Suarez, H. A.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S947 - S947
  • [5] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1122 - S1123
  • [6] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez-Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S123 - S123
  • [7] Prospective Analysis on Tumor Control, Survival, Toxicity and Quality of Life Outcomes of an HDR-Brachytherapy Boost for Prostate Cancer
    Peters, M.
    Nuver, T.
    Rasing, M.
    Noordhoek, M.
    Haverkort, M.
    Schimme, E.
    Schoevers, W.
    Czerwinski, M.
    Pasma, K.
    Minken, A. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E573 - E574
  • [8] HDR brachytherapy as monotherapy in the treatment of prostate cancer
    Komina, Oxana
    Seitz-Kaestner, Christine
    Pajer, Thomas
    Kohl, Bettina
    Hummel, Johann
    Knocke-Abulesz, Tomas-Hendrik
    Nechvile, Elisabeth
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S402 - S403
  • [9] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [10] Prospective experience of quality of life and toxicity of HDR-brachytherapy as interstitial boost for the treatment of prostate carcinoma
    Derakhshani, P.
    Neubauer, S.
    Weise, C.
    Spira, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 27 - 27
12345